Bilaal.Raja
Company record

PDEX  PRO DEX INC

Trailing twelve months to 2026-06-30, as filed 2026-09-03 and not restated since.
Healthcare

Scale

Market cap
$205m
Revenue TTM
$78m
Net income TTM
$14m
Free cash flow
$7m
Composite score
62.0
Sector rank
#2821

Valuation

P / E
15.0
EV / EBITDA
14.8
EV / sales
2.7
FCF yield
3.30%
Yield vs 10-yr
1.42pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 5.28% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
17.6%
EBITDA margin
18.6%
ROE
28.7%
ROIC
23.3%
Revenue growth
16.4%

Insider activity, last 90 days

Net open-market
$-1.40m
Buyers
0
Sellers
3

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Business Strategy and Future Plans Our business today is almost entirely driven by sales of our medical devices. During the third quarter of fiscal 2026, we completed the acquisition of APM, one of our significant suppliers, to help meet the increased demand as a result of this contract extension. Details of our medical device sales by type is as follows (in thousands, except percentages): Sales of our medical device products increased $4.3 million, or 36%, and $11.7 million, or 35%, respectively, for the three and nine months ended March 31, 2026, compared to the corresponding periods of the prior fiscal year. …PRO DEX INC, 10-Q, period ended 2026-03-31, filed 2026-04-30

Read the full passage →